US 8951504
(trimethoxyphenylamino) pyrimidinyl formulations
granted A61KA61K31/5383A61K31/675
Quick answer
US patent 8951504 ((trimethoxyphenylamino) pyrimidinyl formulations) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/5383, A61K31/675, A61K9/0007, A61P